Register here

Date

Tuesday, November 16th 2021 - Saturday, November 20th 2021

Language

English

Organised by

DxPx Conference

Categories

Tags

DxPx Conference is a Partnering Conference focused on (Digital) Diagnostics, Digital Health, Research Tools and Personalized Medicine industry on Nov 16, 2021. DxPx gives you the unique opportunity to talk to over 150+ internationally active investors in effective one-to-one meetings and successfully advance your financing efforts.

Last year we’ve had 440 participants from over 31 countries benefiting from effective, pre-planned one-on-one meetings, panel discussions and startup pitches. This year DxPx will take a place as a hybrid event – one day in person, four days online.

Join now and benefit from:

  • ·       Personal and digital one-to-one meetings with over 150 investors (Roche, Goldman Sachs, GHIF)

  • ·       Five days of potential partnering

  • ·       Live broadcast from our investor panels

  • ·       Virtual exhibition

  • ·       China Focus@ DxPx meeting over 40 Chinese investors (Fosun, BGI and Qiming)

  • ·       Three weeks free trial use of Pitchbook (VC, PE & M&A Database)

  • ·       DxPx Pitch Award

The 8 best applications will pitch in front of a jury of renowned experts including Roche and Euroimmun. In addition, your pitch will be broadcasted live on our partnering platform and uploaded to our website. Apply now and win amazing cash prizes and marketing opportunities for your company! Submission ends September 30th.

 The pandemic has put innovations from the diagnostics and research tool industry in the spotlight of investors and media. Our industry has remarkably proven how effectively it can respond to a worldwide crisis. In many cases partnerships and collaborations are reliable key success factors. Therefore, we at DxPx will grow, evolve and expand our capacities in 2021 to support this.  "  

FLANDERS.BIO MEMBER BENEFIT

flanders.bio members receive a 50% discount on registration.

Please contact us to obtain your promotion code.